Skip to main content

GOLDMAN SACHS GROUP INC

Position in ADPT — Adaptive Biotechnologies Corp

CIK 886982 NEW YORK, NY

Position in ADPT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$45,000,027
-$2,132,820 QoQ
Shares Held
3,242,077
+11.7% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93.95131577689241.ToString("F0")% Shared 0.5841934044132819.ToString("F0")% None 5.464490818694313.ToString("F0")%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Derivatives in ADPT

reported options exposure · as of Jun 30, 2025
CallValue
$1,251,210
CallShares
107,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. ADPT ranks #20 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADPT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $45,000,027 3,242,077
2025-12-31 $47,132,847 2,902,269
2025-09-30 $28,122,584 1,879,852
2025-06-30 $22,454,709 1,927,443
2025-06-30 $1,251,210 107,400
2025-03-31 $14,900,448 2,005,444
2024-12-31 $13,417,563 2,238,126
2024-09-30 $8,955,632 1,749,147
2024-06-30 $3,793,803 1,048,012
2024-03-31 $2,011,773 626,721
2023-12-31 $3,939,892 804,060
2023-09-30 $9,249,596 1,697,174
2023-06-30 $14,421,332 2,149,230
2023-03-31 $13,242,676 1,499,737
2022-12-31 $9,859,992 1,290,575
2022-09-30 $13,574,912 1,906,589
2022-06-30 $10,844,499 1,340,482
2022-03-31 $16,324,295 1,176,102
2021-12-31 $37,021,606 1,319,373
2021-09-30 $43,214,817 1,271,398
2021-06-30 $56,336,337 1,378,765
2021-03-31 $45,558,175 1,131,599
2020-12-31 $50,815,257 859,382
2020-09-30 $60,856,797 1,251,425
2020-06-30 $54,678,736 1,130,193
2020-03-31 $16,878,793 607,588